Zilarvir (GPO)
1237
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection
1237
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection